Evidence map›Paper›PMID 40872938›Full record

ArticleVaccines2025

VVX001 Induces preS-Specific Antibodies Reacting to Common HBV Genotypes in Hepatitis B Virus (HBV) Carrier Mice.

Inna Tulaeva, Maryline Bourgine, Carolin Cornelius-Nikl, Alexander Karaulov, Rainer Henning, Marie-Louise Michel, Rudolf Valenta

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Inna TulaevaInstitute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-5825-2687
Maryline BourgineVirology Department, Institut Pasteur, Université Paris Cité, 75015 Paris, France.ORCID 0000-0002-8850-8073
Carolin Cornelius-NiklInstitute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Alexander KaraulovLaboratory of Immunopathology, Department of Clinical Immunology and Allergology, I. M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
Rainer HenningViravaxx AG, 1190 Vienna, Austria.
Marie-Louise MichelVirology Department, Institut Pasteur, Université Paris Cité, 75015 Paris, France.ORCID 0000-0002-1231-845X
Rudolf ValentaInstitute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.

Funding

Danube Allergy Research Cluster of the country of Lower Austria FA648A0312Viravaxx AG
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibody responseepitopesgenotype cross-reactivitygrass pollen allergy vaccine BM32hepatitis BpreSvaccinationviral vectorVVX001

Identifiers

PMID40872938
PMCPMC12390538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.